Evidence map›Paper›PMID 35205660›Full record

ArticleCancers2022

Heterogeneity of Small Intestinal Neuroendocrine Tumors Metastasis: Biologic Patterns of a Series with Virchow's Node Involvement.

Maria Wedin, Marina Tsoli, Göran Wallin, Eva Tiensuu Janson, Anna Koumarianou, Gregory Kaltsas, Kosmas Daskalakis

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Multifaceted modeling of small intestinal neuroendocrine tumors.Endocrine oncology (Bristol, England) · 2024
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Maria WedinDepartment of Surgery, Faculty of Medicine and Health, Örebro University, 70185 Örebro, Sweden.
Marina Tsoli1st Department of Propaedeutic Internal Medicine, National and Kapodistrian, University of Athens, 11527 Athens, Greece.ORCID 0000-0002-6013-5893
Göran WallinDepartment of Surgery, Faculty of Medicine and Health, Örebro University, 70185 Örebro, Sweden.
Eva Tiensuu JansonDepartment of Medical Sciences, Uppsala University, 75185 Uppsala, Sweden.
Anna KoumarianouHematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.ORCID 0000-0002-4159-2511
Gregory Kaltsas1st Department of Propaedeutic Internal Medicine, National and Kapodistrian, University of Athens, 11527 Athens, Greece.ORCID 0000-0002-5876-7883
Kosmas DaskalakisDepartment of Surgery, Faculty of Medicine and Health, Örebro University, 70185 Örebro, Sweden.ORCID 0000-0003-4224-8912
National and Kapodistrian University of Athens · GRÖrebro University · SEUppsala University · SE

Funding

Royal Swedish Academy of Sciences ME2019-0060
6 · The paper itself

Abstract

Small intestinal neuroendocrine tumors (SI-NETs) may rarely metastasize to the left supraclavicular lymph nodes, also known as Virchow's node metastasis (VM). Data on prevalence, prognostic significance, and clinical course of disease for SI-NET patients with VM is limited. In this retrospective analysis of 230 SI-NET patients treated at two tertiary referral centers, we found nine patients with VM (prevalence 3.9%). Among those, there were 5 females and median age at SI-NET and VM diagnosis was 61 and 65 years, respectively. Two patients had G1 tumors and five G2, while two tumors were of unspecified grade (median Ki67: 7%, range 2-15%). Four patients presented with synchronous VM, whereas five developed metachronous VM after a median of twenty-four months (range: 4.8-117.6 months). Hepatic metastases were present in seven patients, extrahepatic metastases (EM) in eight (six para-aortic distant lymph node metastases, one lung and one pancreatic metastasis), whereas peritoneal carcinomatosis (PC) in two patients. We used a control group of 18 age- and sex-matched SI-NET patients from the same cohort with stage IV disease but no extra-abdominal metastases. There was no difference in best-recorded response to first line treatment according to RECIST 1.1 as well as progression-free survival (PFS) between patients with VM and those in the control group (Chi-square test

Indexed as

small intestinal neuroendocrine neoplasmVirchow’s node metastasis

Identifiers

PMID35205660
PMCPMC8869999
OpenAlexW4213281372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.